AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid Tumors December 16, 2025 08:05 ET | Source:…
- First patient in the world treated with Alpha DaRT® in the brain – - According to the National Brain…
PROVIDENCIALES, Turks and Caicos Islands, Dec. 1, 2025 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, is…
DUBAI, UAE, Nov. 28, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to announce the…
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- Term Structure Labs, backed by Cumberland (DRW), is launching TermMax Alpha on BNB…
DUBAI, United Arab Emirates, Nov. 7, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to…
DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to kick off a brand…
DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to announce…
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data…